Brief: Knight Announces Relaunch Of Akynzeo® In Canada
Dec 1 (Reuters) - Knight Therapeutics Inc GUD.TO :
* KNIGHT ANNOUNCES RELAUNCH OF AKYNZEO® IN CANADA
* KNIGHT THERAPEUTICS INC - ANNOUNCED THAT IT HAS ASSUMED
FULL
COMMERCIAL ACTIVITIES AND IS RELAUNCHING ORAL AKYNZEO IN CANADA
Source text for Eikon: ID:nGNX6zs1tC
Further company coverage: GUD.TO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil